FOI release

annual consumption and/or sales figures of the medication Eliquis

Some or all of the information requested was not provided because we didn't hold it.

Case reference FOI2026/01063

Received 14 September 2026

Published 5 October 2026

Request

I am writing to respectfully request, if possible, access to statistical data regarding the annual consumption and/or sales figures of the medication Eliquis (active substance: apixaban) over the past 10 years. For the purpose of this academic analysis, it would be extremely helpful if the information could be broken down by: • Volume of units sold/dispensed per year; • Total expenditure/sales value (if applicable); • Distribution channel (hospital sector and/or community pharmacy); • Dosage forms and presentations of the product. I guarantee that all data provided will be used exclusively for academic purposes within the framework of the aforementioned project. Thank you in advance for your time and assistance.

Response

See attached

Documents

• FOI2026_01063 (redacted).pdf (523.7 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.